14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of IMM.L
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Immupharma Plc stock downgraded from Hold/Accumulate to Sell Candidate after Wednesday trading session.
(Updated on May 01, 2024)

Sell candidate since May 01, 2024 PDF

The Immupharma Plc stock price fell by -4.24% on the last day (Wednesday, 1st May 2024) from £2.13 to £2.04. During the last trading day the stock fluctuated 9.07% from a day low at £2.02 to a day high of £2.20. The price has fallen in 6 of the last 10 days and is down by -11.33% for this period. Volume has increased on the last day by 68 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 734 thousand shares were bought and sold for approximately £1.49 million.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at £1.85 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 96.82% during the next 3 months and, with a 90% probability hold a price between £3.64 and £6.09 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

IMM.L Signals & Forecast

There are few to no technical positive signals at the moment. The Immupharma Plc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at £2.13 and £2.19. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, April 02, 2024, and so far it has fallen -20.82%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Immupharma Plc gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Immupharma Plc stock

Immupharma Plc finds support from accumulated volume at £2.00 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved £0.183 between high and low, or 9.07%. For the last week, the stock has had daily average volatility of 7.11%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (IMM.L) For The Upcoming Trading Day Of Thursday 2nd

For the upcoming trading day on Thursday, 2nd we expect Immupharma Plc to open at £2.08, and during the day (based on 14 day Average True Range), to move between £1.79 and £2.28, which gives a possible trading interval of +/-£0.247 (+/-12.12%) up or down from last closing price. If Immupharma Plc takes out the full calculated possible swing range there will be an estimated 24.23% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at £2.00 (1.97%) than the resistance at £2.24 (10.07%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Earnings coming up

Immupharma Plc will release earnings BMO on Thursday, May 09, 2024. We will update the financials statements for Immupharma Plc, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 20.45% in the first trading day after earnings release.

Is Immupharma Plc stock A Buy?

The Immupharma Plc stock holds several negative signals and despite the positive trend, we believe Immupharma Plc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -3.093 Sell Candidate Downgraded

Predicted Opening Price for Immupharma Plc of Thursday, May 2, 2024

Fair opening price May 2, 2024 Current price
£2.08 ( 2.41%) £2.04

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for IMM.L

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.27 11.40 %
R2 2.20 7.97 %
R1 2.15 5.84 %
Current price: 2.04
Support S1 2.01 -1.03 %
S2 1.97 -3.15 %
S3 1.90 -6.58 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.48 21.62 %
R2 2.45 20.39 %
R1 2.24 10.07 %
Current price 2.04
Support S1 2.00 -1.97%
S2 1.92 -5.90%
S3 1.86 -8.85%

IMM Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Dec 14, 2021 Dec 14, 2021 Dec 14, 2021 £300.00 5,357.14%

FAQ

What is the symbol for Immupharma Plc Stock and on which exchange is it traded?
The symbol for Immupharma Plc is IMM.L and it is traded on the XLON (London Stock Exchange).

Should I buy or sell Immupharma Plc Stock?
The Immupharma Plc stock holds several negative signals and despite the positive trend, we believe Immupharma Plc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

How to buy Immupharma Plc Stock?
Immupharma Plc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Immupharma Plc Stock.

What's the current price of Immupharma Plc Stock?
As of the end of day on the May 01, 2024, the price of an Immupharma Plc (IMM.L) share was £2.04.

What is the 52-week high and low for Immupharma Plc Stock?
The 52-week high for Immupharma Plc Stock is £3.80 and the 52-week low is £0.82.

What is the market capitalization of Immupharma Plc Stock?
As of the May 01, 2024, the market capitalization of Immupharma Plc is 8.849M.

When is the next earnings date for Immupharma Plc?
The upcoming earnings date for Immupharma Plc is May 09, 2024.
Click to get the best stock tips daily for free!

About Immupharma Plc

Immupharma Plc ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease. Its other product candidates include BioAMB, a... IMM.L Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT